Cardiovascular Disease and Dyslipidemia: Beyond LDL

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|9|861-870

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.9, 2011-03, pp. : 861-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyslipidemia Treatment and Cardiovascular Disease in the Renal Patient

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 894-907

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 10, 2007-04 ,pp. : 1021-1030

Bentham Science Publishers

Access to resources Recommend Favorite

The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 908-921

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3858-3868

Bentham Science Publishers

Access to resources Recommend Favorite